Solid Biosciences Inc.
SLDB
$6.40
$0.091.43%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -154.08M | -139.68M | -124.70M | -102.44M | -90.69M |
| Total Depreciation and Amortization | 1.69M | 2.54M | 2.46M | 2.18M | 2.36M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 25.56M | 22.97M | 19.38M | 10.86M | 6.36M |
| Change in Net Operating Assets | 4.22M | 7.50M | 2.85M | -1.79M | -3.41M |
| Cash from Operations | -122.62M | -106.67M | -100.01M | -91.19M | -85.38M |
| Capital Expenditure | -722.00K | -631.00K | -654.00K | -540.00K | -908.00K |
| Sale of Property, Plant, and Equipment | 5.00K | 5.00K | 5.00K | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -31.90M | -4.43M | -15.44M | -8.82M | -22.10M |
| Cash from Investing | -32.62M | -5.06M | -16.09M | -9.36M | -23.01M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -525.00K | -608.00K | -473.00K | -345.00K | -225.00K |
| Issuance of Common Stock | 200.53M | 205.84M | 128.02M | 121.46M | 118.08M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.68M | -306.00K | -5.11M | -5.11M | -5.11M |
| Cash from Financing | 198.32M | 204.92M | 122.44M | 116.00M | 112.75M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 43.09M | 93.20M | 6.34M | 15.46M | 4.36M |